title: Differential expression of the Ly49G(B6), but not the Ly49G(BALB), receptor isoform during natural killer cell reconstitution after hematopoietic stem cell transplantation.
abstract: Inhibitory natural killer (NK) cell receptors specific for major histocompatibility complex class I (MHC-I) molecules include Ly49 receptors in mice and killer immunoglobulin-like receptors (KIR) in humans. The "licensing" or "arming" models imply that engagement of these receptors to self MHC-I molecules during NK cell development educates NK cells to be more responsive to cancer and viral infection. We recently reported that hematopoietic stem cell transplantation (HSCT) induced rapid and preferential expansion of functionally competent Ly49G(+), but not other Ly49 family, NK cells independent of NK cell licensing via Ly49-MHC-I interactions. We now extend these studies to evaluate expression of the two Ly49G receptor isoforms Ly49G(B6) and Ly49G(BALB), using mice with different MHC-I haplotypes that express one or both of the isoforms. NK cells from CB6F1 (H-2(bxd)) hybrid mice express two different alleles for Ly49G receptor, Ly49G(B6) and Ly49G(BALB). We found that CB6F1 mice had more Ly49G(B6+) NK cells than Ly49(BALB+) NK cells, and that only Ly49G(B6+) NK cells increased in relative numbers and in Ly49G mean fluorescence intensity values after HSCT similar to the B6 parental strain. We further observed that Ly49G(+) NK cells in BALB/c (H-2(d)) and BALB.B (H-2(b)) mice, which have the same background genes, recover slowly after HSCT, in contrast to Ly49G(+) NK cells in B6 (H-2(b)) recipients. The difference in expression of Ly49G(B6) relative to Ly49G(BALB) was linked to differences in the activity of the Pro1 promoter between the two alleles. Thus, we conclude that the Ly49G(B6) receptor dominates Ly49G expression on NK cells after HSCT in strains in which that allele is expressed. The data suggest that Ly49 allelic polymorphism within a particular Ly49 family member can differentially affect NK cell recovery after HSCT depending on the background genes of the recipient, not on the MHC-I haplotype.
authors.affiliation: Department of Microbiology and Immunology, University of Nevada, Reno, Reno, Nevada.
authors.forename: Isabel
authors.initials: I
authors.lastname: Barao
authors.forename: Paul W
authors.initials: PW
authors.lastname: Wright
authors.forename: Can M
authors.initials: CM
authors.lastname: Sungur
authors.forename: Stephen K
authors.initials: SK
authors.lastname: Anderson
authors.forename: Doug
authors.initials: D
authors.lastname: Redelman
authors.forename: William J
authors.initials: WJ
authors.lastname: Murphy
mesh_terms: D000818:Animals; D000950:Antigens, Ly / Q000096:biosynthesis* / Q000276:immunology; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D007694:Killer Cells, Natural / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D020033:Protein Isoforms; D014162:Transfection; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D000950:Antigens, Ly; D020033:Protein Isoforms
keywords: Hematopoietic stem cell transplantation; Ly49G; Natural killer cell
references.citation: Immunity. 2004 Jul;21(1):55-66
references.pmid: 15345220
references.citation: Immunity. 1999 Jul;11(1):67-77
references.pmid: 10435580
references.citation: J Exp Med. 2005 Apr 4;201(7):1145-55
references.pmid: 15809355
references.citation: Annu Rev Immunol. 2001;19:291-330
references.pmid: 11244039
references.citation: Nature. 2005 Aug 4;436(7051):709-13
references.pmid: 16079848
references.citation: Immunol Rev. 1997 Feb;155:41-52
references.pmid: 9059881
references.citation: J Immunol. 2009 Apr 15;182(8):4572-80
references.pmid: 19342631
references.citation: Nat Immunol. 2010 Apr;11(4):321-7
references.pmid: 20190757
references.citation: Blood. 2005 Apr 15;105(8):3051-7
references.pmid: 15632206
references.citation: Curr Opin Immunol. 2003 Apr;15(2):233-7
references.pmid: 12633675
references.citation: Blood. 2005 Jun 1;105(11):4416-23
references.pmid: 15728129
references.citation: J Exp Med. 1995 Aug 1;182(2):293-303
references.pmid: 7629495
references.citation: Blood. 2002 Oct 15;100(8):3026-33
references.pmid: 12351417
references.citation: J Immunol. 2004 Feb 1;172(3):1414-25
references.pmid: 14734717
references.citation: J Leukoc Biol. 1999 Sep;66(3):512-20
references.pmid: 10496323
references.citation: Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4778-83
references.pmid: 10781084
references.citation: PLoS Genet. 2008 Nov;4(11):e1000254
references.pmid: 19008943
references.citation: Immunol Today. 1990 Jul;11(7):237-44
references.pmid: 2201309
references.citation: Nat Rev Immunol. 2006 Jul;6(7):520-31
references.pmid: 16799471
references.citation: Blood. 2007 Jul 1;110(1):433-40
references.pmid: 17371948
references.citation: Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S57-63
references.pmid: 19892024
references.citation: J Exp Med. 2001 Feb 5;193(3):307-15
references.pmid: 11157051
references.citation: Immunity. 2006 Aug;25(2):331-42
references.pmid: 16901727
references.citation: Immunol Rev. 2001 Jun;181:170-84
references.pmid: 11513138
references.citation: Blood. 2002 Nov 15;100(10):3633-8
references.pmid: 12393617
references.citation: Nat Rev Immunol. 2005 Mar;5(3):201-14
references.pmid: 15719024
references.citation: Blood. 2011 Jun 30;117(26):7032-41
references.pmid: 21498673
references.citation: Blood. 2009 Apr 16;113(16):3875-84
references.pmid: 19179302
references.citation: Immunity. 2009 Mar 20;30(3):337-47
references.pmid: 19249231